Anterior Temporal Epilepsy Neuropsychological Assessment of Faces

NCT02888925 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-07-24

No results posted yet for this study

Summary

The purpose is to evaluate neuropsychological effects of anterior temporal epilepsy in face perception by comparison of performances of epileptic patients and control individuals, sex-, age- and socio-educational level-matched.

Secondary purposes are to prospectively evaluate neuropsychological impact of anterior temporal lobectomy performed for surgical treatment of anterior temporal epilepsy on face perception (exploratory study).

Conditions

  • Anterior Temporal Epilepsy
  • Anterior Temporal Lobectomy
  • Face Perception

Interventions

OTHER

Mooney test

OTHER

Benton Face Recognition test

OTHER

Face inversion effect test

OTHER

Face composite effect test

OTHER

Cambridge Face Memory Test

OTHER

Matching different view test

OTHER

Memorizing and recognition of new faces test

OTHER

Memorizing and recognition of new objects test

OTHER

Recognition of celebrities and access to semantic information test

PROCEDURE

Lobectomy

In patients with anterior temporal epilepsy, at 6 to 12 months after inclusion, depending on surgery decision taken after pre-surgery conventional intercritical assessment

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Louis Maillard · Service de Neurologie, Hôpital Central, CHU de Nancy, France

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2017-09-30
Completion
2020-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02888925 on ClinicalTrials.gov